SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,000 | 0.0% | 21,100 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 21,100 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $7,000 | -81.1% | 21,100 | 0.0% | 0.00% | -81.2% |
| Q3 2015 | $37,000 | -43.1% | 21,100 | -27.5% | 0.02% | -33.3% |
| Q2 2015 | $65,000 | -18.8% | 29,100 | -29.2% | 0.02% | -25.0% |
| Q1 2015 | $80,000 | +42.9% | 41,100 | +94.8% | 0.03% | +39.1% |
| Q4 2014 | $56,000 | -12.5% | 21,100 | 0.0% | 0.02% | -20.7% |
| Q3 2014 | $64,000 | -25.6% | 21,100 | 0.0% | 0.03% | -17.1% |
| Q2 2014 | $86,000 | -5.5% | 21,100 | 0.0% | 0.04% | -20.5% |
| Q1 2014 | $91,000 | -18.0% | 21,100 | 0.0% | 0.04% | -13.7% |
| Q4 2013 | $111,000 | -16.5% | 21,100 | 0.0% | 0.05% | -26.1% |
| Q3 2013 | $133,000 | +26.7% | 21,100 | 0.0% | 0.07% | +4.5% |
| Q2 2013 | $105,000 | – | 21,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |